TOKYO -- Japanese pharmaceutical companies including Daiichi Sankyo and Fujifilm Holdings are increasing efforts to develop biopharmaceutical talent, aiming for 50% to 100% growth in such experts as they seek to catch up with overseas rivals.
Pharmaceuticals
Japan drugmakers aim for biopharma surge with expanded talent pool
Daiichi Sankyo and Fujifilm Holdings boost training to develop experts
Chugai Pharmaceutical began focusing on biopharmaceuticals before other Japanese drugmakers. (Photo by Chugai Pharmaceutical)
Read Next
Latest on Pharmaceuticals
